# Arquimea Ingeniera

> Arquimea Ingeniera is a VC fund in Madrid backing Medical and Pharmaceutical. See 1 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Madrid, Spain
- Total investments: 1
- Last investment: Mar 2021
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/arquimea/
- Website: http://www.arquimea.com

Arquimea Ingeniera is a VC fund in Madrid focused on Medical and Pharmaceutical. ARQUIMEA develops electronic, microelectronic, and electro-mechanic systems and components, including smart actuators and mechanisms, sensing systems, integrated circuits (IC) and robotic parts. ARQUIMEA’s products and technologies are suitable for those markets and sectors demanding innovation, quality, high performance and reliability, such asAerospace, Defence & Security, Industry, Automotive, Medical or Agroindustry.ARQUIMEA is committed to offer its clients products adapted to their needs and expert technical advice, with the goal of collaborating in the progress and development of the society in which we live.Production processes at ARQUIMEA are developed following the strictest and most exhaustive international quality regulations.

## Contacts

5 contacts available for Arquimea Ingeniera. Shizune tracks 7 team members at Arquimea Ingeniera. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/arquimea-ingeniera?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 1 | 100% |
| Pharmaceutical | 1 | 100% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Daniel González Gutiérrez | Space Programs Director | 0 | — |
| Diego Fernandez | Founder & President | 0 | — |
| Ferran Tejada Valero | General Manager | 0 | — |
| Idoia Picossi | Chief Financial Officer | 0 | — |
| Jesús Delgado Alonso | CEO, Arquimea USA | 0 | — |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Vaxdyn | Vaxdyn develops vaccines using novel technology. They offers pathogen vaccines for preventing antibiotics-resistant infections. Their customers' inquiries are addressed through phone, email, and online applications. | $355.5K | Seed | Mar 08, 2021 |  |

1 of 1 investments shown.

## Co-investors
- [Bionova Capital](https://shizune.co/investors/profile/hovione-capital) — VC Fund, 2 deals together
- [Fundacion Botin](https://shizune.co/investors/profile/fundacion-botin) — VC Fund, 1 deal together
- [Reig Jofre](https://shizune.co/investors/profile/reig-jofre) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Arquimea Ingeniera invest in?

Arquimea Ingeniera invests primarily in Medical and Pharmaceutical startups, most often at Seed stage. Most of the 1 investments tracked by Shizune back companies in Spain. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Arquimea Ingeniera?

Public channels for Arquimea Ingeniera include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Arquimea Ingeniera?

The team at Arquimea Ingeniera includes Daniel González Gutiérrez (Space Programs Director), Diego Fernandez (Founder & President) and Ferran Tejada Valero (General Manager), among 7 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co